Amycolatopsis sp. Vanillin Bioconversion Mutants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The bioconversion of ferulic acid to vanillin in Amycolatopsis sp. strains typically involves a lag period due to suppressed expression of the ech-fcs operon, leading to delayed vanillin production and subsequent oxidation to vanillic acid, which reduces yield and efficiency.

Innovation Solution

Genetically engineered Amycolatopsis sp. strains with mutations in the echR gene, specifically deletions, frameshift, or promoter mutations, are developed to relieve repression of the ech-fcs operon, allowing immediate vanillin production without a lag period and preventing conversion to vanillic acid by inactivating the vanillin dehydrogenase gene using CRISPR technology, maintaining the non-GMO status.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the ech-fcs operon expression is suppressed during growth on glucose, then the microorganism can efficiently utilize glucose as carbon source, but vanillin production is delayed due to lag period when ferulic acid is added

Engineering Contradiction:
Improvevanillin production rateVSAvoidlag period duration
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by pre-inducing the ech-fcs operon expression during the growth phase on glucose-containing medium. This is achieved by adding ferulic acid during the exponential growth phase, which triggers early expression of the enzymes needed for vanillin production. As a result, when ferulic acid is later added as the sole carbon source, the lag period is eliminated because the enzymatic machinery is already prepared and expressed at high levels.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If ferulic acid is added to induce ech-fcs operon expression, then vanillin synthesis can be initiated, but vanillin is subsequently oxidized to vanillic acid reducing yield

Engineering Contradiction:
Improvevanillin production amountVSAvoidvanillin yield
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The patent applies the taking out principle by removing the harmful oxidation step from the metabolic pathway. This is achieved by deleting or inactivating the vdh gene that encodes vanillin dehydrogenase, the enzyme responsible for oxidizing vanillin to vanillic acid. By taking out this enzymatic step, vanillin accumulates as the end product without being further metabolized, thereby preserving yield and preventing substance loss.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If the vdh gene is active to metabolize vanillin, then the microorganism can continue fermentation metabolism, but vanillin production yield is reduced due to conversion to vanillic acid

Engineering Contradiction:
Improvefermentation efficiencyVSAvoidvanillin accumulation
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The patent applies the blessing in disguise principle by converting the harmful effect of active vdh gene (which reduces vanillin yield through oxidation) into a beneficial outcome. This is achieved by strategically inactivating the vdh gene only after high-level vanillin production has been established, or by using conditional expression systems where vdh is inactive during the vanillin accumulation phase. The fermentation metabolism continues through alternative pathways while vanillin is preserved as the final product, transforming the potential harm into a benefit for vanillin production.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The mutant strains produce significantly higher amounts of vanillin within shorter times, with some strains producing up to 400% more vanillin than wild-type strains within 8 hours, while minimizing vanillic acid accumulation, thus enhancing bioconversion efficiency and simplifying the production process.

Implementation Method 1

In the first step, ferulic acid is subjected to non-oxidative deacetylation to yield vanillin. This step is mediated by two enzymes, namely, feruloyl-coenzyme A (CoA) synthetase encoded by the fcs gene

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

enoyl-CoA hydratase/aldolase encoded by the ech gene

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

The conversion of vanillin to vanillic acid is mediated by vanillin dehydrogenase enzyme coded by the vdh gene

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

Genetically engineered Amycolatopsis sp. strains with mutations in the echR gene, specifically deletions, frameshift, or promoter mutations, are developed to relieve repression of the ech-fcs operon, allowing immediate vanillin production without a lag period and preventing conversion to vanillic acid by inactivating the vanillin dehydrogenase gene using CRISPR technology

Methodology Applied
Scientific EffectGenetic engineering:

Data Source

PatentUS20240060097A1Bioconversion of ferulic acid to vanillin
Publication Date: 2024.02.22 BASF SE
  • US20240060097A1 patent drawing
  • US20240060097A1 patent drawing
  • US20240060097A1 patent drawing

AI summary

A chemical mutagenic approach and a screening protocol were followed to select mutant strains of Amycolatopsis sp. with the ability to produce natural vanillin at high yields without any lag period. The resulting mutant strains are free of any exogeneous genetic elements and can be qualified as non-genetically modified organisms (non-GMOs) for regulatory purposes.